0108
Hepatitis B · Phase III
Bepirovirsen enters priority review after B-Well
GSK reported a 19% functional cure rate in the pooled analysis and 26% among participants with lower baseline viral activity.
peptideencyclopedia.info
Research radar
Figures from sponsor releases are clearly identified and may change after peer-reviewed publication or regulatory review.
Complete library
Type it naturally: a body area, a concern, a condition, a brand, or the scientific name.
Use the search bar above or choose a body area, concern, condition, or filter.
● Last editorial review Aug 21, 2026
100 entries from the source document
+52 additions from research monitoring
Primary sources for recent developments